Drug Synthesis Articles & Analysis
26 news found
Considerable attention has been drawn to the use of nanoparticles with exceptional novel properties as enzyme drug carriers due to advances in their synthesis and characterization, as this offers promise in addressing some of these challenges. ...
Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and ...
By integrating artificial intelligence into drug synthesis, the AI-synthesizer not only accelerates the development timelines of small molecule drugs but also achieves greater precision and cost-efficiency. ...
Alfa Chemistry provides a wide variety of these intermediates which meet strict quality and safety requirements required for the drug development process. These intermediates (ammonium acids, organic acids, esters and heterocyclic compounds) allow us to innovate in drug synthesis, which in turn leads to more effective and precise ...
The company's newly introduced customized synthesis services cater to the specific needs and requirements of customers. By leveraging cutting-edge technologies and state-of-the-art facilities, Alfa Chemistry ensures high-quality and reliable synthesis of biotinylation reagents. One of the key focuses of Alfa Chemistry's custom synthesis services ...
This cutting-edge technology provides scientists and researchers with an innovative platform to study human organs in a way that was previously impossible, promising to accelerate drug discovery, reduce the need for animal testing and ultimately transform the future of medicine. ...
Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the advantages of small molecular weight, high tumor penetration, low immunogenicity, large-scale synthesis using solid phase synthesis, low production cost, relatively good pharmacokinetics, and so on. ...
Lenalidomide, as an oral immunomodulatory drug, revealed a good safety profile. Parecoxib Sodium Alfa Chemistry offers high-quality parecoxib sodium as API to support the amide prodrug of the cyclooxygenase II (COX-2)-selective inhibitor, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, which has anti-inflammatory, analgesic, and antipyretic activities. ...
Specializing in drug formulation, the highly specialized CRO service provider CD Formulation has accumulated abundant experience in the custom synthesis of increased bioavailability excipients. ...
As an active player in the chemical industry, Alfa Chemistry decided to combine the power of computational chemistry with drug design and synthesis. This move aims to largely enhance the overall drug discovery efficiency and open up new possibilities for the pharmaceutical industry. ...
Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug development and drug manufacturing projects. “With advanced facilities, we are capable of providing CMO, CRO, and CDMO services globally for the design, development, and production of various ...
The potential applications are subject to the requisite clinical and regulatory commercialization processes. The global psychedelic drugs market is expected to gain significant market growth in the forecast period from 2022 to 2029. ...
Peptide drug conjugate (PDC) is emerging as a novel type of conjugate drug, showing advantageous features over antibody-drug conjugates (ADCs). ...
CD Bioparticles has developed various Lipid System for research use, which can be applied in drug delivery, tracking & imaging, lipid synthesis and production, unique and functional liposome particle preparation and production, as well as adjuvants development for immunotherapy & vaccine development. ...
He joined the University of Alberta in 2000 where he is the founder and director of the Drug Development and Innovation Centre, Faculty of Pharmacy and Pharmaceutical Sciences. ...
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of prostaglandins products to support drug delivery related research. ...
Currently, its APIs & Intermediates mainly fall into two categories: featured APIs and patented original research drugs. The synthesis of featured APIs is admittedly more challenging than that of general ones. ...
Currently, its APIs & Intermediates mainly fall into two categories: featured APIs and patented original research drugs. The synthesis of featured APIs is admittedly more challenging than that of general ones. ...
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO headquartered in Nottingham, UK, with expertise across a range of therapeutic and biological target classes today announced a collaboration agreement in AI for new drug design. ...
ByIktos
Continued the recruitment for two Phase 2 clinical trials of BIT225 for treatment of HIV-1 infection at sites in Australia and Thailand. Continued the design, synthesis and testing of new compounds under its HIV-1 program, with the aim of identifying a next generation lead anti-HIV-1 drug. Continued the design, synthesis and testing of new ...